Portfolio monetization

A strategy in which a company or inventor monetizes a collection of related patents through licensing, litigation, or structured sale rather than asserting individual patents opportunistically. Litigation funders frequently structure portfolio deals in which a single capital commitment covers assertion costs across multiple patents and multiple defendants, enabling diversification of claim-specific risk. Portfolio monetization is attractive to funders because a single adverse claim construction or IPR outcome may not destroy the entire portfolio's value, and because licensing campaigns against multiple defendants create negotiating leverage and settlement optionality. The economics of portfolio deals typically involve revenue-sharing arrangements tied to gross recovery, with the funder's return tied to aggregate portfolio performance rather than any single case.

Funders favor portfolio structures over single-patent campaigns because an adverse claim construction or IPR loss on one patent does not eliminate the entire investment — the remaining portfolio continues generating settlement leverage against other defendants or other patents in the family. Pricing is built on a weighted-average expected value across the constituent patents and defendant pool rather than a single binary outcome, and funders typically negotiate revenue-share terms tied to aggregate campaign proceeds so early, smaller settlements help fund continued assertion against remaining targets.